Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02469727 · ClinicalTrials.gov registry record · NA

mHealth Intervention to Promote Cancer Survivors' Physical Activity

A NA study, sponsored by Seattle Children's Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02469727 is a NA study that has completed, run by Seattle Children's Hospital. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02469727, a NA study, has completed, sponsored by Seattle Children's Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The Primary Goal is to conduct a 5-10 week randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mHealth app. The target population will be childhood cancer survivors 14-18 years old recruited from Seattle Children's Hospital. For the intervention group, peer influences will be engaged via a private, social network (e.g. a Facebook group) customized for survivors. Measurements will be completed (1) at baseline, prior to randomization, and (2) during the final week of the intervention period (follow-up measure). This study will provide initial proof of concept and allow for further customization of the intervention for childhood cancer survivors in anticipation of a future, larger proposal to study physical activity and related outcomes over a multi-year period.

Interventions

  • BEHAVIORAL Fitbit
  • BEHAVIORAL Facebook group

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-07
Est. Completion 2016-07
Phase NA

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT02469727

The ClinicalTrials.gov registry entry for NCT02469727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fitbit is the first listed.

NCT02469727 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02469727 about?

NCT02469727 is a clinical study titled "mHealth Intervention to Promote Cancer Survivors' Physical Activity". The Primary Goal is to conduct a 5-10 week randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mHealth app. The target population will be childhood cancer survivors 14-18 years old recruited from Seattle Children's H...

What is the current status of trial NCT02469727?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-07. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02469727?

The interventions under investigation include: Fitbit (BEHAVIORAL), Facebook group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02469727?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.